REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Medycyna Dab Sp. z o.o. (Poland)

Main Activities: Ambulatory Health Care Services
Secondary Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers | Pharmacies and Drug Stores | Department Stores | Lessors of Real Estate | Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | All Other Miscellaneous Schools and Instruction | General Medical and Surgical Hospitals
Full name: Medycyna Dab Sp. z o.o. Profile Updated: May 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Medycyna Dab Sp. z o.o. is an enterprise in Poland, with the main office in Katowice. The company operates in the Ambulatory Health Care Services industry. It was incorporated on August 02, 2017. The company’s latest financial report indicates a net sales revenue increase of 36.99% in 2023. Its total assets grew by 67.88% over the same period. In, 2023, the company’s net profit margin increased by 3.24%.

Headquarters
Ul. Debowa 64
Katowice; Slaskie; Postal Code: 40-108

Contact Details: Purchase the Medycyna Dab Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Medycyna Dab Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Medycyna Dab Sp. z o.o. report to view the information.
Incorporation Date:
August 02, 2017
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
30%
Purchase this report to view the information.
20%
Company Performance
Financial values in the chart are available after Medycyna Dab Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
36.99%▲
Total operating revenue
37.11%▲
Operating profit (EBIT)
54.66%▲
Net Profit (Loss) for the Period
54.04%▲
Total assets
67.88%▲
Total equity
155.4%▲
Operating Profit Margin (ROS)
3.65%▲
Net Profit Margin
3.24%▲
Return on Equity (ROE)
-40.04%▼
Quick Ratio
-0.52%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo